| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
aminoacylase 1 | 0.653 | 0.577 | 6.9E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
aminoacylase 3 | 0.839 | 0.154 | 5.4E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 12 | 2 | 2005 | 2019 | ||||||||
|
ADAM metallopeptidase domain 12 | 0.565 | 0.731 | 5.7E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2013 | ||||||||
|
ADAM metallopeptidase domain 23 | 0.650 | 0.500 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ArfGAP with dual PH domains 1 | 0.839 | 0.154 | 0.53 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
adenylate cyclase 2 | 0.695 | 0.308 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
adenylate cyclase activating polypeptide 1 | 0.510 | 0.846 | 0.52 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1999 | 2019 | ||||||||
|
ADCYAP receptor type I | 0.561 | 0.769 | 7.2E-10 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2006 | 2009 | ||||||||
|
adhesion G protein-coupled receptor B1 | 0.695 | 0.231 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
alcohol dehydrogenase 1A (class I), alpha polypeptide | 0.647 | 0.577 | 1.7E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | 0.656 | 0.462 | 1.5E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2002 | 2002 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
adenosine kinase | 0.584 | 0.769 | 3.1E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2000 | 2017 | ||||||||
|
adrenoceptor alpha 2A | 0.578 | 0.615 | 8.2E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 1994 | 2019 | ||||||||
|
adrenoceptor beta 3 | 0.533 | 0.731 | 2.5E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2017 | ||||||||
|
argonaute RISC component 1 | 0.656 | 0.577 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
argonaute RISC catalytic component 2 | 0.501 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
agouti related neuropeptide | 0.488 | 0.769 | 7.0E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 |